Efficacy and Safety of the Lidocaine 5 percent Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen.
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2017
At a glance
- Drugs Lidocaine (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 04 Dec 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 04 Dec 2008 Actual patient number (93) added as reported by ClinicalTrials.gov.
- 04 Dec 2008 Status changed from active, no longer recruiting to completed.